Video

Q&A With David Friedman From North Shore LIJ: Current and Future Heart Failure Treatments and the Development of Sports Cardiology

Author(s):

Heart failure may be one of the most common conditions a cardiologist sees on a daily basis but there are also many misconceptions about its treatment and diagnosis. Whether on the football field or running an endurance race there are also other issues doctors are working to address across the scope of the cardiology field.

Heart failure may be one of the most common conditions a cardiologist sees on a daily basis but there are also many misconceptions about its treatment and diagnosis. Whether on the football field or running an endurance race there are also other issues doctors are working to address across the scope of the cardiology field.

David Friedman, MD, from North Shore LIJ Discussed these issues and more during a recent interview with MD Magazine.

Patients living through their 80's and 90's is becoming more common these days and that is thanks in large part to advancements made in the treatment of heart failure and other cardiac conditions. Even still there are many misconceptions about this common issue.

With heart failure being such a common problem for patients there is continuous work being done to find the most effective treatments. Some of that work has looked at using diabetes medication to treat these patients.

Whether it was Hank Gathers collapsing on the basketball court or an otherwise healthy high school football player dying on the field during summer practice there have been many tragic deaths in the sports world. How these deaths can be prevented is the focus of a new area of cardiology looking at these questions and more.

Related Videos
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.